Clovis Oncology

1 follower


Clovis Oncology is advancing the fight against cancer.


Founded in 2009, Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Industries

Headquarters

Stage

Employees

Links

Org chart

Patrick J. Mahaffy
President & CEO

Patrick J. Mahaffy

Collapse
Lindsey Rolfe
EVP, Clinical Development and Pharmacovigilance & Chief Medical Officer
Paul E. Gross
EVP & General Counsel
Thomas Fuglsang Harding
EVP & Chief Scientific Officer
Kenton Wride
Senior Director, Biostatistics
Peter Leopardi
Senior Vice President, U.s. Commercial
Gillian Ivers-Read
EVP Regulatory Affairs Tech Ops
Nathalie Lvoff
Public Policy Communication And Market Access Director France And Benelux
Rhonda Jernigan
Director Global Pharmacovigilance Compliance
Charmin King
Associate Manager
Frank Failoni
Division Manager
Ger Kemmy
Senior QA Manager And Responsible Person
Mary S Mack
Quality Systems Manager
Deepa Karajgar
Senior Study Management Associate
James Samuda
Head Of Commercial Operations
Curt Wolfgang
Vice President Clinical Development